[1] 孔艳, 孔祥. 妊娠期肝内胆汁淤积症免疫因素的研究进展. 中华妇幼临床医学杂志(电子版), 2015, 11:798-800. [2] 陈芳, 赵爱民, 肖海望,等. 妊娠期肝内胆汁淤积症与母体免疫失衡的相关性. 山西医药杂志, 2017, 46:1621-1623. [3] 中华医学会妇产科学分会产科学组. 妊娠期肝内胆汁淤积症诊疗指南(2015). 中华妇产科杂志, 2015, 31:481-485. [4] 浦雯绮, 蔡奚梅, 陆丽丹. 妊娠期肝内胆汁淤积症患者人类白细胞抗原G与Th1/Th2细胞因子的相关性. 中国医药导报, 2016, 13:90-93. [5] Larson SP, Kovilam O, Agrawal DK. Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Clin Immunol, 2016, 12:39-48. [6] 高翔, 张华, 庞秋梅,等. 乙型肝炎病毒感染对妊娠期肝内胆汁淤积症患者母婴免疫系统及妊娠结局的影响. 中国医药导报, 2015, 12:59-62. [7] 郑皓文, 孔祥. 妊娠期肝内胆汁淤积症发病机制的免疫学研究进展.国际医药卫生导报, 2018, 24:3738-3741. [8] Muzzio DO, Ziegler KB, Ehrhardt J , et al. Marginal zone B cells emerge as critical component of pregnancy wellbeing. Reproduction, 2016, 151:29-37. [9] Wang S, Zhu X, Xu Y , et al. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4 + T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface. Hum Reprod, 2016, 31:700-711. [10] Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis, 2016, 20:177-189. [11] 王增芳, 王萍萍, 王增艳, 等. PTPRO对妊娠期肝内胆汁淤积症患者Th1/Th2细胞偏倚的影响. 江苏医药, 2015,41:2157-2159. [12] 杨旭波. 茵陈蒿汤加味对妊娠期肝内胆汁淤积症患者Th1/Th2平衡的影响.现代中西医结合杂志, 2019, 28:1885-1887. [13] 蔡奚梅, 陆丽丹, 蒋廷旺, 等. Th1/Th2平衡对妊娠期肝内胆汁淤积症影响.中国处方药, 2018, 16:3-4. [14] Ozler A, Ucmak D, Evsen MS, et al. Immune mechanisms and the role of oxidative stress in intrahepatic cholestasis of pregnancy. 2014, 39:198-202. [15] 吴珺, 杜艳芹, 杨东亮. 2018年肝脏免疫学研究若干进展. 中华肝脏病杂志, 2019, 27:241-243. |